Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer

被引：0
|
作者：
Thomas Kuehr
Paul Ruff
Bernardo L Rapoport
Stephen Falk
Francis Daniel
Conrad Jacobs
Neville Davidson
Josef Thaler
Blandine Boussard
James Carmichael
机构：
[1] Hospital Barmherzige Schwestern vom heiligen Kreuz,Department of Medical Oncology
[2] Johannesburg Hospital,Plymouth Oncology Centre
[3] The Medical Oncology Centre of Rosebank,East Cape Oncology Centre
[4] Bristol Oncology Centre,Oncology Suite
[5] Derriford Hospital,Cancer Research Campaign Department of Clinical Oncology
[6] St George's Hospital,undefined
[7] Broomfield Hospital,undefined
[8] Global Medical Affairs Oncology,undefined
[9] City Hospital,undefined
来源：
BMC Cancer | / 4卷
关键词：
Neutropenia; Dose Level; Irinotecan; Febrile Neutropenia; Maximum Tolerate Dose;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer
    Kuehr, T
    Ruff, P
    Rapoport, BL
    Falk, S
    Daniel, F
    Jacobs, C
    Davidson, N
    Thaler, J
    Boussard, B
    Carmichael, J
    BMC CANCER, 2004, 4 (1)
  • [2] Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer
    Glimelius, B
    Ristamäki, R
    Kjaer, M
    Pfeiffer, P
    Skovsgaard, T
    Tveit, KM
    Linné, T
    Frödin, JE
    Boussard, B
    Oulid-Aïssa, D
    Pyrhönen, S
    ANNALS OF ONCOLOGY, 2002, 13 (12) : 1868 - 1873
  • [3] Irinotecan combined or alternated with bolus 5-fluorouracil and folinic acid versus the Mayo Clinic regimen in the first-line therapy of advanced colorectal cancer
    Graeven, U
    Ridwelski, K
    Artandi, M
    Espana, P
    Schölmerich, J
    Rosales, AM
    Carlsson, G
    Borner, M
    Boussard, B
    Schmiegel, W
    ONCOLOGY REPORTS, 2005, 13 (04) : 681 - 688
  • [4] Phase II study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer
    Ji, SH
    Park, YS
    Lee, J
    Lim, DH
    Park, BB
    Park, KW
    Kang, JH
    Lee, SH
    Park, JO
    Kim, K
    Kim, WS
    Jung, CW
    Im, YH
    Kang, WK
    Park, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (04) : 214 - 217
  • [5] A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients
    C Garufi
    E Bria
    B Vanni
    A M R Zappalà
    I Sperduti
    E Terzoli
    British Journal of Cancer, 2003, 89 : 1870 - 1875
  • [6] A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients
    Garufi, C
    Bria, E
    Vanni, B
    Zappalà, AMR
    Sperduti, I
    Terzoli, E
    BRITISH JOURNAL OF CANCER, 2003, 89 (10) : 1870 - 1875
  • [7] First-line chemotherapy with fluorouracil and folinic acid for advanced colorectal cancer in elderly patients - A phase II study
    Daniele, B
    Rosati, G
    Tambaro, R
    Ottaiano, A
    De Maio, E
    Pignata, S
    Iaffaioli, RV
    Rossi, A
    Manzione, L
    Gallo, C
    Perrone, F
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 (03) : 228 - 233
  • [8] Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study
    Kalofonos, HP
    Aravantinos, G
    Kosmidis, P
    Papakostas, P
    Economopoulos, T
    Dimopoulos, M
    Skarlos, D
    Bamias, A
    Pectasides, D
    Chalkidou, S
    Karina, M
    Koutras, A
    Samantas, E
    Bacoyiannis, C
    Samelis, GF
    Basdanis, G
    Kalfarentzos, F
    Fountzilas, G
    ANNALS OF ONCOLOGY, 2005, 16 (06) : 869 - 877
  • [9] Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer:: a Phase II study
    Francois, Eric
    Berdah, Jean-Francois
    Chamorey, Emmanuel
    Lesbats, Gerard
    Teissier, Eric
    Codoul, Jean-Francois
    Badetti, Jean-Luc
    Hebert, Christophe
    Mari, Veronique
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (06) : 931 - 936
  • [10] Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study
    Eric François
    Jean-François Berdah
    Emmanuel Chamorey
    Gérard Lesbats
    Eric Teissier
    Jean-François Codoul
    Jean-Luc Badetti
    Christophe Hébert
    Véronique Mari
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 931 - 936
12345